Pharmarise Holdings Corporation (2796.T)
JPY 563.0
(-2.26%)
JPY 563.0
(-2.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 22.09 Billion JPY | 34.46% |
| 2022 | 16.43 Billion JPY | -3.6% |
| 2021 | 17.04 Billion JPY | -7.31% |
| 2020 | 18.39 Billion JPY | -4.52% |
| 2019 | 19.26 Billion JPY | 3.55% |
| 2018 | 18.6 Billion JPY | -0.21% |
| 2017 | 18.64 Billion JPY | 0.02% |
| 2016 | 18.64 Billion JPY | -4.07% |
| 2015 | 19.43 Billion JPY | 5.51% |
| 2014 | 18.41 Billion JPY | -4.34% |
| 2013 | 19.25 Billion JPY | -0.33% |
| 2012 | 19.31 Billion JPY | 37.64% |
| 2011 | 14.03 Billion JPY | 13.0% |
| 2010 | 12.41 Billion JPY | 4.6% |
| 2009 | 11.87 Billion JPY | 37.81% |
| 2008 | 8.61 Billion JPY | 10.79% |
| 2007 | 7.77 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 20.78 Billion JPY | -5.96% |
| 2023 Q4 | 22.09 Billion JPY | 19.66% |
| 2023 Q1 | 16.57 Billion JPY | 0.83% |
| 2023 FY | 22.09 Billion JPY | 34.46% |
| 2023 Q3 | 18.46 Billion JPY | 26.69% |
| 2023 Q2 | 14.57 Billion JPY | -12.04% |
| 2022 FY | 16.43 Billion JPY | -3.6% |
| 2022 Q2 | 16.61 Billion JPY | 0.88% |
| 2022 Q1 | 16.46 Billion JPY | -3.4% |
| 2022 Q3 | 16.1 Billion JPY | -3.08% |
| 2022 Q4 | 16.43 Billion JPY | 2.07% |
| 2021 Q4 | 17.04 Billion JPY | -0.85% |
| 2021 FY | 17.04 Billion JPY | -7.31% |
| 2021 Q3 | 17.19 Billion JPY | 2.99% |
| 2021 Q2 | 16.69 Billion JPY | -3.6% |
| 2021 Q1 | 17.31 Billion JPY | -5.84% |
| 2020 Q4 | 18.39 Billion JPY | 0.78% |
| 2020 FY | 18.39 Billion JPY | -4.52% |
| 2020 Q1 | 18.56 Billion JPY | -3.61% |
| 2020 Q2 | 17.64 Billion JPY | -4.99% |
| 2020 Q3 | 18.25 Billion JPY | 3.45% |
| 2019 Q4 | 19.26 Billion JPY | 2.29% |
| 2019 FY | 19.26 Billion JPY | 3.55% |
| 2019 Q3 | 18.83 Billion JPY | 1.78% |
| 2019 Q2 | 18.5 Billion JPY | -3.37% |
| 2019 Q1 | 19.14 Billion JPY | 2.94% |
| 2018 Q2 | 18.67 Billion JPY | 5.96% |
| 2018 Q4 | 18.6 Billion JPY | -0.07% |
| 2018 FY | 18.6 Billion JPY | -0.21% |
| 2018 Q1 | 17.62 Billion JPY | -5.47% |
| 2018 Q3 | 18.61 Billion JPY | -0.31% |
| 2017 Q2 | 19.01 Billion JPY | -2.88% |
| 2017 Q1 | 19.58 Billion JPY | 5.05% |
| 2017 FY | 18.64 Billion JPY | 0.02% |
| 2017 Q4 | 18.64 Billion JPY | -2.72% |
| 2017 Q3 | 19.16 Billion JPY | 0.77% |
| 2016 Q1 | 18.67 Billion JPY | -3.87% |
| 2016 FY | 18.64 Billion JPY | -4.07% |
| 2016 Q4 | 18.64 Billion JPY | -2.15% |
| 2016 Q3 | 19.05 Billion JPY | 4.5% |
| 2016 Q2 | 18.23 Billion JPY | -2.4% |
| 2015 Q4 | 19.43 Billion JPY | -8.22% |
| 2015 FY | 19.43 Billion JPY | 5.51% |
| 2015 Q1 | 19.45 Billion JPY | 5.67% |
| 2015 Q2 | 20.99 Billion JPY | 7.89% |
| 2015 Q3 | 21.17 Billion JPY | 0.84% |
| 2014 Q3 | 19.25 Billion JPY | 0.63% |
| 2014 FY | 18.41 Billion JPY | -4.34% |
| 2014 Q1 | 19.72 Billion JPY | 2.45% |
| 2014 Q2 | 19.13 Billion JPY | -2.98% |
| 2014 Q4 | 18.41 Billion JPY | -4.36% |
| 2013 Q2 | 18.91 Billion JPY | -3.71% |
| 2013 Q4 | 19.25 Billion JPY | 2.87% |
| 2013 FY | 19.25 Billion JPY | -0.33% |
| 2013 Q1 | 19.64 Billion JPY | 1.7% |
| 2013 Q3 | 18.71 Billion JPY | -1.07% |
| 2012 Q1 | 13.63 Billion JPY | -2.85% |
| 2012 Q2 | 18.71 Billion JPY | 37.3% |
| 2012 Q4 | 19.31 Billion JPY | 4.35% |
| 2012 Q3 | 18.51 Billion JPY | -1.11% |
| 2012 FY | 19.31 Billion JPY | 37.64% |
| 2011 Q2 | 14.27 Billion JPY | 13.29% |
| 2011 Q1 | 12.6 Billion JPY | 1.46% |
| 2011 Q4 | 14.03 Billion JPY | -3.55% |
| 2011 FY | 14.03 Billion JPY | 13.0% |
| 2011 Q3 | 14.54 Billion JPY | 1.93% |
| 2010 Q2 | 11.87 Billion JPY | 2.21% |
| 2010 Q1 | 11.62 Billion JPY | -2.11% |
| 2010 FY | 12.41 Billion JPY | 4.6% |
| 2010 Q3 | 12.36 Billion JPY | 4.07% |
| 2010 Q4 | 12.41 Billion JPY | 0.45% |
| 2009 Q4 | 11.87 Billion JPY | 0.0% |
| 2009 FY | 11.87 Billion JPY | 37.81% |
| 2008 Q3 | 8.73 Billion JPY | 6.42% |
| 2008 Q2 | 8.2 Billion JPY | 0.0% |
| 2008 Q4 | 8.61 Billion JPY | -1.34% |
| 2008 FY | 8.61 Billion JPY | 10.79% |
| 2007 FY | 7.77 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| HEARTSEED INC | 450.19 Million JPY | -4808.794% |
| Cawachi Limited | 85.94 Billion JPY | 74.286% |
| Qol Holdings Co., Ltd. | 64.93 Billion JPY | 65.969% |
| MatsukiyoCocokara & Co. | 209.56 Billion JPY | 89.455% |
| Welcia Holdings Co., Ltd. | 307.48 Billion JPY | 92.813% |
| Create SD Holdings Co., Ltd. | 86.23 Billion JPY | 74.374% |
| NIHON CHOUZAI Co.,Ltd. | 136.73 Billion JPY | 83.838% |
| COSMOS Pharmaceutical Corporation | 245.53 Billion JPY | 91.0% |
| Tsuruha Holdings Inc. | 241.47 Billion JPY | 90.848% |
| Ohki Healthcare Holdings Co.,Ltd. | 112.17 Billion JPY | 80.3% |
| Satudora Holdings Co.,Ltd. | 35.89 Billion JPY | 38.441% |
| Kusuri No Aoki Holdings Co., Ltd. | 186.03 Billion JPY | 88.121% |
| Medical System Network Co., Ltd. | 52.97 Billion JPY | 58.283% |
| Shinnihonseiyaku Co., Ltd. | 5.84 Billion JPY | -278.278% |
| Sugi Holdings Co.,Ltd. | 158.62 Billion JPY | 86.068% |
| YAKUODO HOLDINGS Co., Ltd. | 37.75 Billion JPY | 41.466% |
| Astena Holdings Co., Ltd. | 38.65 Billion JPY | 42.828% |
| Genky DrugStores Co., Ltd. | 67.25 Billion JPY | 67.141% |
| Ain Holdings Inc. | 113.99 Billion JPY | 80.614% |
| Sundrug Co.,Ltd. | 168.21 Billion JPY | 86.862% |